We discuss the advances in the use AI, large scale data sets, and IPSC’s within the drug discovery paradigm.
Read the full interview to find out more.
Micheal J. Fox Foundation
Matthew E. Kennedy PhD
Merck Research Laboratories
On behalf of: BACE Inhibitor Discovery & Development Program
Michael Irizarry M.D.
Eli Lilly and Company